Jeffrey McKenna, MD
MOHS-Micrographic Surgery · Charleston, ILNPI 1396713780
Payments from drug & device makers
Across 466 payments — averaging $20.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Sun Pharmaceutical Industries Inc.$2K
- Regeneron Healthcare Solutions, Inc.$902
- AbbVie$876
- Pfizer$832
- Johnson & Johnson$733
- plus $3K from 22 others
What the payments were for
- Food & beverage$8,65890%
- Education$96410%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 59 | $1,819 |
| Sun Pharmaceutical Industries Inc. | 87 | $1,664 |
| Regeneron Healthcare Solutions, Inc. | 35 | $902 |
| AbbVie | 52 | $876 |
| Pfizer | 56 | $832 |
| Johnson & Johnson(2 entities) | 31 | $733 |
| Sanofi | 24 | $633 |
| Lilly USA, LLC | 25 | $376 |
| Novartis | 12 | $261 |
| Dermavant Sciences, Inc. | 25 | $184 |
| Organogenesis Inc. | 8 | $178 |
| UCB, Inc. | 5 | $133 |
| Boehringer Ingelheim | 5 | $124 |
| Biofrontera Inc. | 6 | $113 |
| E.r. Squibb & Sons, L.L.C. | 5 | $107 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Surgenex LLC | 4 | $87 |
| Amgen | 4 | $76 |
| Galderma Laboratories, L.p. | 4 | $73 |
| Incyte Corporation | 3 | $62 |
| Organon | 4 | $62 |
| Arcutis Biotherapeutics, Inc. | 3 | $51 |
| Genentech USA, Inc. | 2 | $51 |
| Convatec Inc. | 1 | $32 |
| Kerecis Limited | 1 | $28 |
| Strata Skin Sciences, Inc. | 2 | $27 |
| Fresenius Kabi USA, LLC | 1 | $21 |
| Aroa Biosurgery Incorporated | 1 | $18 |
How this compares
$9,622 in reported general payments places this provider in the 80th percentile of 40 mohs-micrographic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 12 | $249,939 |
| Dupixent PenDupilumab | 17 | $66,120 |
| Fluorouracil | 159 | $11,478 |
| Minocycline Hcl | 438 | $2,224 |
| Imiquimod | 75 | $2,097 |
| Clobetasol Propionate | 13 | $825 |
| Ketoconazole | 14 | $531 |
| Mupirocin | 62 | $379 |
| Triamcinolone Acetonide | 27 | $296 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Charleston
- Scott ZahnerHinsdale$55K
- Melanie ZahnerHinsdale$23K
- Kelly ParkNorthbrook$11K
- Owen KramerElmhurst$10K
- Todd JohnsonChicago$10K
- Simon YooChicago$10K
- Daniel SchlessingerChicago$8K
- Aleksandar KrunicChicago$8K
- Ross PearlmanChicago$8K
- Sarah WilsonChicago$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.